RASBs, renin-angiotensin system blockers; ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin-2 receptor 1 blockers; SD, standard deviation; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer. This evidence concerns the gene ACE and small cell lung carcinoma.